172 results match your criteria: "Center for Regulatory Science[Affiliation]"
Clin Pharmacol Ther
January 2025
Center for Regulatory Science, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
Recent discussions about the utilization of real-world data (RWD) and real-world evidence (RWE) have been more focused on drug development for regulatory approval rather than during the post-marketing stage. In Japan, RWD/RWE have been practically utilized as an external control for drug approval. Most cases were related to orphan diseases where the feasibility of conducting randomized controlled clinical trials was generally low.
View Article and Find Full Text PDFJAMA Pediatr
December 2024
Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
Transplant Cell Ther
December 2024
Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska.
Chimeric antigen receptor T (CAR T) cell therapies have emerged as a valuable treatment modality for patients with plasma cell disorders. As the population of patients receiving CAR T therapies grows, the identification and management of associated rare toxicities become increasingly crucial. This study aims to identify safety signals associated with commercial anti-B-cell maturation antigen (BCMA) CAR T therapies using the Food and Drug Administration Adverse Event Reporting System (FAERS).
View Article and Find Full Text PDFClin Pharmacol Ther
December 2024
Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
JAMA Pediatr
December 2024
Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts.
Clin Transl Sci
December 2024
Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
Whether or not vascular endothelial growth factor pathway inhibitors (VPIs) increase the risk of artery dissection is still unknown. This study aimed to quantitatively evaluate the possibility of artery dissection as a class effect of VPIs using nationwide real-world data. This cohort study was conducted based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB), which spans nearly the entire Japanese population of over 100 million individuals.
View Article and Find Full Text PDFOncology
November 2024
Department of Urology, Toranomon Hospital, Tokyo, Japan.
Introduction: Understanding the metastatic patterns is crucial for the treatment of malignancies. This study aimed to identify the characteristic organ metastases of primary malignancies, including rare malignancies, and classify them according to their metastatic patterns.
Methods: We extracted data on primary malignancies and organ metastases from the Annual of Pathological Autopsy Cases in Japan recorded in 1993-2021.
Am J Health Promot
November 2024
Christina Lee Brown Envirome Institute, School of Medicine, University of Louisville, Louisville, KY, USA.
Purpose: Health care providers (HCP) are uniquely positioned to advise against electronic cigarette (e-cigarette) use, potentially influencing youth perceptions of e-cigarette harms. However, research examining these associations is scant. We examined whether HCP e-cigarette-related advice is associated with youth e-cigarette harm perceptions.
View Article and Find Full Text PDFJAMA Pediatr
November 2024
Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston.
Theor Popul Biol
December 2024
Department of Statistics, University of Oxford, 24-29 St Giles', Oxford OX1 3LB, United Kingdom. Electronic address:
Motivation: A main challenge in molecular evolution is to find computationally efficient mutation models with flexible assumptions that properly reflect genetic variation. The infinite sites model assumes that each mutation event occurs at a site never previously mutant, i.e.
View Article and Find Full Text PDFClin Pharmacol Ther
October 2024
School of Pharmacy, Sungkyunkwan University, Suwon, Korea.
PLoS One
September 2024
American Heart Association Tobacco Center for Regulatory Science, Dallas, Texas, United States of America.
Understanding the association between initial experimentation with a tobacco product and subsequent patterns of tobacco use among youth is important to informing prevention activities for youth in the US. We conducted an online survey from August to October 2017 among youth aged 13-18 years. The current analysis focused on respondents reporting initial experimentation with any tobacco product (n = 2,022).
View Article and Find Full Text PDFAm J Gastroenterol
January 2025
School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.
Introduction: Anti-tumor necrosis factor (anti-TNF) therapy may improve insulin sensitivity, and its impact during pregnancy remains unclear. We aimed to assess the risk of gestational diabetes mellitus (GDM) associated with anti-TNF treatment among pregnant women with inflammatory bowel disease (IBD).
Methods: This nationwide cohort study included patients with IBD in Korea from 2010 to 2021.
Health Policy
November 2024
KPM Center for Public Management, University of Bern, Freiburgstr. 3, 3010 Bern, Switzerland; Swiss Institute for Translational and Entrepreneurial Medicine (sitem-insel), Freiburgstr. 3, 3010 Bern, Switzerland.
Countries with small and/or less-resourced regulatory authorities that operate outside of a larger medical product regulatory system face a regulatory strategy dilemma. These countries may rely on foreign well-resourced regulators by recognising the regulatory decisions of large systems and following suit (regulatory reliance); alternatively, such countries may extend formal decision recognition to regulators in multiple other jurisdictions with similar oversight and public health goals, following a system which we call regulatory pluralism. In this policy comment, we discuss three potential limitations to regulatory pluralism: (i) regulatory escape, in which manufacturers exploit regulatory variation and choose the lowest regulatory threshold for their product; (ii) increased fragmentation and complexity for countries adopting this approach, which may, in turn, lead to inconsistent processes; and (iii) loss of international bargaining power in developing regulatory policies.
View Article and Find Full Text PDFJ Law Biosci
September 2024
Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA.
Biologics are playing an increasingly important role in health care globally but are placing a substantial burden on payers. The development of biosimilars-drugs that are highly similar to and have no clinically meaningful differences from originator biologics-is critical to improving the affordability and accessibility of these medications. Medicines regulators, however, have had varied success with biosimilars to date.
View Article and Find Full Text PDFPharmacoepidemiol Drug Saf
September 2024
Center for Regulatory Science, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
Drug Alcohol Depend Rep
September 2024
Department of Behavioral Science, College of Medicine, University of Kentucky, Lexington, KY 40536, USA.
Introduction: Both electronic cigarette (e-cigarette) and social media use among youth are public health concerns. While the health impacts of extensive social media use and frequent use of e-cigarettes have been discussed independently in the literature, little is known about the relationship between the two. This study aims to examine the potential association between extensive social media use and the frequency of current, e-cigarette use among United States (US) youth.
View Article and Find Full Text PDFNPJ Digit Med
August 2024
Department of International Health, Care and Public Health Research Institute (CAPHRI), Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands.
Regulatory frameworks for artificial intelligence (AI) are needed to mitigate risks while ensuring the ethical, secure, and effective implementation of AI technology in healthcare and population health. In this article, we present a synthesis of 141 binding policies applicable to AI in healthcare and population health in the EU and 10 European countries. The EU AI Act sets the overall regulatory framework for AI, while other legislations set social, health, and human rights standards, address the safety of technologies and the implementation of innovation, and ensure the protection and safe use of data.
View Article and Find Full Text PDFEpidemiol Health
October 2024
Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, Korea.
Addiction
July 2024
Department of Communication, College of Arts and Sciences, University of Louisville, Louisville, KY, USA.
Background And Aims: Disposable electronic cigarette (e-cigarette) use is becoming more popular among US youth, given the shifting landscape in product marketing, availability and regulation. This study aimed to estimate the prevalence of and test factors associated with the most used e-cigarette product (disposable versus other) among US youth aged 9-18 years who currently use e-cigarettes.
Design, Setting And Participants: This was an observational study using cross-sectional data from the US-based 2021 and 2022 National Youth Tobacco Surveys (n = 48 704).
Drug Alcohol Depend Rep
September 2024
Department of Communication, College of Arts and Sciences, University of Louisville, Louisville, KY 40292, USA.
Introduction: Cannabis use is increasing due to several factors including the adoption of laws legalizing its use across the United States (US). We examined changes in current cannabis use among US youth and adults and by key sociodemographic groups.
Methods: Using data from the 2013-2022 National Survey on Drug Use and Health (n=543,195), we estimated the prevalence of (2013-2019, 2020, 2021-2022) and trends in (2013-2019, 2021-2022) current (i.
N Engl J Med
July 2024
From the Center for Health Law Studies, Saint Louis University School of Law, St. Louis (M.S.S.); Harvard Business School and the Harvard-MIT Center for Regulatory Science - both in Boston (A.D.S.); Hasso Plattner Institute, University of Potsdam, Potsdam, Germany (A.D.S.); and Duke Law School and the Duke-Margolis Center for Health Policy, Durham, NC (A.K.R.).
J Dermatolog Treat
December 2024
Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
J Korean Med Sci
June 2024
School of Pharmacy, Sungkyunkwan University, Suwon, Korea.
Background: Cancer patients have an increased risk of cardiovascular outcomes and are susceptible to coronavirus disease 2019 (COVID-19) infection. We aimed to assess the cardiovascular safety of COVID-19 vaccination for cancer patients in South Korea.
Methods: We conducted a self-controlled case series study using the K-COV-N cohort (2018-2021).
Biostatistics
October 2024
Department of Molecular Life Sciences and SIB Swiss Institute of Bioinformatics, University of Zurich, Winterthurerstrasse 190, Zurich, 8057, Switzerland.
Although transcriptomics data is typically used to analyze mature spliced mRNA, recent attention has focused on jointly investigating spliced and unspliced (or precursor-) mRNA, which can be used to study gene regulation and changes in gene expression production. Nonetheless, most methods for spliced/unspliced inference (such as RNA velocity tools) focus on individual samples, and rarely allow comparisons between groups of samples (e.g.
View Article and Find Full Text PDF